Clinical Trials
11 trialsNCT05498766 2024-06-24
Effect and Safety of Huaier Granule Versus SOX Regimen in Gastric Cancer Patients
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 4 Not yet recruiting
NCT06385873 2024-05-13
RC48 Combined With Adebrelimab, Apatinib and S-1 as Neoadjuvant Therapy in Locally Advanced Gastric Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Not yet recruiting
NCT01515748 2023-12-13
PRODIGY
Sanofi
Phase 3 Completed
NCT01516944 2020-02-13
Perioperative Chemotherapy for Potentially Resectable Gastric Cancer
Hebei Medical University
Phase 2/3 Completed
NCT04202484 2019-12-17
Tripletrumab Combined With Oxaliplatin and Teggio (SOX) in First-line Treatment of Gastric and Gastroesophageal Junction Adenocarcinoma
RenJi Hospital
Phase 2 Unknown
NCT03941561 2019-05-31
S-1 for 9 Months Versus 1 Year for Stage II Gastric Cancer (SMAC）
Fudan University
Phase 3 Recruiting
NCT03475615 2018-03-23
A Study of Intraperitoneal Paclitaxel in Combination With SOX Compared With SOX Alone in Gastric Cancer With Malignant Ascites
Fudan University
Phase 3 Unknown
NCT02527785 2017-08-23
Study of Oxaliplatin, Irinotecan, and S-1 in Gastric Cancer
Hallym University Medical Center
Phase 2 Completed
NCT02504229 2015-07-21
DC-CIK In Combination With Chemotherapy ( Gio / Oxaliplatin or Cisplatin ) Versus First-line Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma Randomized Controlled Phase II Clinical Study of Treatment
Beijing Biohealthcare Biotechnology Co.,Ltd
Phase 2 Unknown
NCT02008422 2013-12-11
Clinical Study of Endostar Injection Concomitant With SOX Protocols to Treat Advanced Gastric Cancer
Xinjiang Medical University
Phase 3 Unknown
NCT01198392 2011-07-25
Trial of S-1 Plus Cisplatin in Gastric Cancer
Sun Yat-sen University
Phase 3 Unknown